Mineralocorticoid receptor (MR) blockers (MRBs) are expected to exert antihypertensive and organ-protective effects in MR-associated hypertension caused by lifestyle factors such as excessive salt intake, DM, and obesity [13]. The gene discussed is NR3C2; the disease is Obesity.